New triple therapy shows promise for tough liver cancers
Disease control
Recruiting now
This study tests a new approach for people with liver cancer that has spread to the portal vein (the main blood vessel to the liver). Participants will receive radiation therapy before surgery, along with two drugs (camrelizumab and apatinib) before and after surgery. The goal is…
Phase: PHASE2 • Sponsor: Yongyi Zeng • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC